This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Nikolaus Klaus-Peter Stengele
Introduction
Nikolaus Klaus-Peter Stengele is a notable inventor based in Pleiskirchen, Germany. He has made significant contributions to the field of molecular analysis, particularly in the area of nucleic acid sequencing. His innovative approach utilizes tunneling junctions to enhance the detection and sequencing of molecules.
Latest Patents
Stengele holds a patent for "Tunneling junctions for sequencing." This invention allows for the analysis of molecules, such as the sequencing of nucleic acid molecules, through tunneling recognition at a tunneling junction. The technology enables the detection of individual nucleotides by labeling specific nucleotides with a moiety, which generates a signal with a suitable signal-to-noise ratio. This method facilitates fast detection of nucleotides using a tunneling current, primarily passing through the moiety rather than the nucleotide itself.
Career Highlights
Stengele is currently associated with Roche Sequencing Solutions, Inc., where he continues to develop innovative solutions in the field of sequencing technologies. His work has the potential to revolutionize how nucleic acids are analyzed, making the process faster and more efficient.
Collaborations
Some of his notable coworkers include Yann A Astier and Juraj Topolancik. Their collaborative efforts contribute to advancing the research and development of sequencing technologies.
Conclusion
Nikolaus Klaus-Peter Stengele's contributions to the field of molecular analysis through his patented tunneling junction technology exemplify the innovative spirit of modern science. His work at Roche Sequencing Solutions, Inc. continues to pave the way for advancements in nucleic acid sequencing.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
